Clinical practice guidelines
Evidence-based clinical guidance for myeloma diagnosis and management. Expert-authored resources to support health professionals in patient care.
This resource hub provides clinicians with practical, evidence-based guidance for the diagnosis and management of myeloma and related conditions.
From clinical practice guidelines to position statements, the Medical and Scientific Advisory Group (MSAG) author these documents to support health professionals in delivering patient care.
MSAG clinical practice guidelines
Newly diagnosed transplant ineligible guidelines
A clinical guideline outlining recommended treatments for patients newly diagnosed with multiple myeloma who are not eligible for stem cell transplantation.
Treatment of patients with relapsed refractory multiple myeloma
An Australia‑specific, evidence‑based guideline for personalised treatment of relapsed or refractory multiple myeloma, prioritising early use of effective therapies within PBS access limits.
Newly diagnosed transplant eligible guideline
An Australian guideline for treating newly diagnosed, transplant‑eligible multiple myeloma, centred on induction therapy, autologous stem cell transplantation, and maintenance.
Selinexor
A practical resource for Australian clinicians to optimize the use of selinexor, focusing on maximizing efficacy while minimizing and managing predictable toxicities through proactive supportive care and patient engagement.
Systemic AL Amyloidosis guidelines
An Australian guideline outlining diagnosis, staging, treatment and supportive care for systemic AL amyloidosis.
Optimal care pathway for people with multiple myeloma
A guideline for clinicians to manage each step of the care pathway from diagnosis to treatment, supportive care and disease progression.
Evidence-based guidelines on the use of imaging for the diagnosis, assessment and management of myeloma and associated plasma cell disorders.
Prevention of infection in myeloma
An evidence‑based Australian guideline outlining infection risk assessment, screening, prophylaxis and vaccination strategies for patients with multiple myeloma.
VRd
Guidelines for using bortezomib, lenalidomide, and dexamethasone (VRd) as first-line treatment for multiple myeloma, emphasising its avaliability in Australia, efficacy, and the need to tailor regimens based on patient fitness and toxicity risk.
Waldenström Macroglobulinaemia (2022)
An Australian consensus guideline for the diagnosis and treatment of Waldenström macroglobulinaemia, covering frontline and relapsed therapies within current PBS access.
Downloadable resources
Access our comprehensive guides and infosheets whenever you need them. Download PDFs to read on your device or save for later.
These resources cover everything from understanding your diagnosis to managing treatment, giving you reliable information you can refer back to anytime.
Order your own copy
Prefer a printed version? We can send our guides directly to your home at no cost. Having a physical copy on hand can make it easier to read, share with family, or take notes as you go.
Myeloma – a comprehensive guide
This guide is written for people who have been diagnosed with myeloma, their families, carers and friends.
Telephone Support Line
Talk directly with our specialist myeloma nurses who understand exactly what you’re going through.
Use our simple booking form below to schedule your personalised consultation at a time that works for you.
Get the expert guidance and emotional support you need, when you need it most.
Connect with us
Stay informed with the latest myeloma research, treatment updates and support resources. We offer tailored newsletters for both patients and healthcare professionals with relevant information and community updates.
